Medexus Pharmaceuticals (MEDXF) Q2 2025 Earnings

25JunConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.06
-0.02
0.03
0.08

Details

Expected EPS
-0.062683
Actual EPS
-0.02
Surprise EPS
0.04
Surprise Percent
+68.09%

Description

Medexus Pharmaceuticals (MEDXF) has reported earnings of -0.02 per share for Q2 2025.

0 Comments

Share your thoughts